Literature DB >> 8570854

Somatostatin and macrophage function: modulation of hydrogen peroxide, nitric oxide and tumor necrosis factor release.

T C Chao1, H P Cheng, R J Walter.   

Abstract

Recent studies have shown that somatostatin modulates lymphocyte function, but the effects of somatostatin on macrophage function are not clearly defined. In the present study, peritoneal macrophages (Mluminal diameter) obtained from male rats were treated in vitro with somatostatin or octreotide and their effects on the release of hydrogen peroxide (H2O2), nitrite, and tumor necrosis factor (TNF) determined. Macrophages treated with somatostatin (10(-9) M to 10(-7) M) or octreotide (10(-8) M and 10(-7) M) released significantly greater amounts of PMA-stimulated H2O2 than did the untreated controls. In addition, 10(-9) M of somatostatin significantly enhanced PMA-stimulated H2O2 release by LPS-treated Mluminal diameter. Octreotide had no effect on H2O2 release by LPS-treated Mluminal diameter. At concentrations of 10(-14) M, 10(-13) M, or greater than 10(-8) M, somatostatin or octreotide suppressed nitrite release by Mluminal diameter. Somatostatin or octreotide did not affect nitrite release by LPS-treated Mluminal diameter. On the other hand, Mluminal diameter treated with 10(-11) M of somatostatin or octreotide released greater amounts of TNF than did the untreated controls. In contrast, TNF release by Mluminal diameter treated with 10(-9) M to 10(-5) M of somatostatin or 10(-7) M to 10(-5) M of octreotide was less than that of the controls. Anti-TNF antibody (1:1000) caused a reduction in the release of H2O2 and nitrite. These findings demonstrate that somatostatin and octreotide modulate the release of H2O2, nitric oxide, and TNF by Mluminal diameter depending on the concentration of hormones used.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8570854     DOI: 10.1016/0167-0115(95)00051-c

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  5 in total

Review 1.  Growth hormone. A paracrine growth factor?

Authors:  S Harvey; K L Hull
Journal:  Endocrine       Date:  1997-12       Impact factor: 3.633

2.  Octreotide negates the benefit of galantide when used in the treatment of caerulein-induced acute pancreatitis in mice.

Authors:  Savio G Barreto; Colin J Carati; Ann C Schloithe; James Toouli; Gino T P Saccone
Journal:  HPB (Oxford)       Date:  2010-08       Impact factor: 3.647

3.  Nitric oxide and octreotide in retinal ischemia-reperfusion injury.

Authors:  Ulku Celiker; Necip Ilhan
Journal:  Doc Ophthalmol       Date:  2002-11       Impact factor: 2.379

4.  Differential between protein and mRNA expression of CCR7 and SSTR5 receptors in Crohn's disease patients.

Authors:  Nathalie Taquet; Serge Dumont; Jean-Luc Vonesch; Didier Hentsch; Jean-Marie Reimund; Christian D Muller
Journal:  Mediators Inflamm       Date:  2010-02-01       Impact factor: 4.711

5.  Somatostatin Derivate (smsDX) Attenuates the TAM-Stimulated Proliferation, Migration and Invasion of Prostate Cancer via NF-κB Regulation.

Authors:  Zhaoxin Guo; Zhaoquan Xing; Xiangyu Cheng; Zhiqing Fang; Chao Jiang; Jing Su; Zunlin Zhou; Zhonghua Xu; Anders Holmberg; Sten Nilsson; Zhaoxu Liu
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.